Your session is about to expire
← Back to Search
Dry Needling for Muscle Spasms After Stroke
Study Summary
This trial is testing the effects of dry needling on spasticity in people with chronic stroke.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My diabetes is not under control.My motor nerves are damaged and don't respond well to treatment.I have a severe fear of needles.I am over 18 and do not have any known brain injuries or conditions.I had a stroke over a year ago, have stable health, and experience stiffness in my ankle or wrist.I have a condition affecting my blood vessels.I am under 18 years old.I experience unusual bleeding.My immune system is weak.I am experiencing anxiety or distress.I have a heart condition such as a past heart attack, heart failure, or use a pacemaker.I have swelling in my arm or leg due to lymphedema.I am able to understand and follow the study's requirements.I have a history of epilepsy.I am allergic to certain metals.
- Group 1: Individuals with spasticity resulting from stroke
- Group 2: Individuals with no known neurological injury
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there room in this research endeavor for additional participants?
"Indeed, the information on clinicaltrials.gov advertises this trial as actively recruiting participants. It was first publicised on September 8th 2020 and most recently modified on July 22nd 2022, with 40 patients sought from one site."
What objectives are being sought to be achieved with this trial?
"The main outcome of this clinical trial, which will be monitored at baseline, immediately after DDN, 90 minutes afterwards and 72 hours later, is evaluating the participants' perception of cutaneous stimuli using perception thresholds. Other objectives include assessing spasticity with Modified Ashworth Scale (mAS), pain levels via Visual Analog Scale (VAS) and brain activity through Electroencephalography (EEG). A reduction in mAS indicates a decrease in spasticity, lower VAS score signals lowered pain intensity whereas altered EEG patterns signify potential changes to CNS functionality from the intervention."
What is the enrollment size of this trial thus far?
"Affirmative. The clinicaltrials.gov website shows that this trial, which was published on September 8th 2020, is actively recruiting patients. Approximately 40 individuals must be recruited from 1 specific medical facility."
Share this study with friends
Copy Link
Messenger